Inflam Cancer Research Results

Inflam, inflammation: Click to Expand ⟱
Source:
Type:
Cancer and inflammation are closely linked, with chronic inflammation contributing to the development and progression of cancer. Various inflammatory mediators and cells are involved in this process.
Scientific Papers found: Click to Expand⟱
6475- 1,8-Cin,    1,8-Cineole inhibits platelet-leukocyte aggregate formation by reducing P-selectin expression
- in-vitro, HNSCC, NA
*P-sel↓, Inflam↓, AntiTum↑, AntiAg↑,
2326- 2DG,    Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2–Signal Transducer and Activator of Transcription 3 Pathway
- in-vivo, Nor, NA
PKM2↓, Inflam↓, TNF-α↓, IL6↓, OS↑,
5444- AG,    A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine
- Review, Var, NA
*Imm↑, *antiOx↑, *Inflam↓, AntiTum↑, eff↑, chemoP↑, Dose↝, TumCMig↓, TumCP↓, Akt↓, GSK‐3β↓, MMP2↓, MMP9↓, EMT↓, PI3K↓, Akt↓, NF-kB↓, Inflam↓, TGF-β1↓, TNF-α↓, IL6↓, Fas↓, FasL↓, NOTCH1↓, JNK↓, TumCG↓,
4397- AgNPs,    Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity
- NA, Wounds, NA
selectivity↑, tumCV↓, antiOx↑, Inflam↓,
2659- AL,    Allicin inhibits spontaneous and TNF-α induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells
- in-vitro, HCC, HT29 - in-vitro, HCC, Caco-2
IL1β↓, IL8↓, Inflam↓,
2666- AL,    Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals
- Review, Var, NA
Inflam↓, AntiCan↑, ROS↑, MAPK↑, JNK↑, TumAuto↑, other↑, Dose↝, MALAT1↓, Wnt↓, β-catenin/ZEB1↓,
278- ALA,    The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment
- Review, NA, NA
ROS↑, NRF2↑, Inflam↓, frataxin↑, *BioAv↓, ChemoSen↑, Hif1a↓, eff↑, FAK↓, ITGB1↓, MMP2↓, MMP9↓, EMT↓, Snail↓, Vim↓, Zeb1↓, P53↑, MGMT↓, Mcl-1↓, Bcl-xL↓, Bcl-2↓, survivin↓, Casp3↑, Casp9↑, BAX↑, p‑Akt↓, GSK‐3β↓, *antiOx↑, *ROS↓, selectivity↑, angioG↓, MMPs↓, NF-kB↓, ITGB3↓, NADPH↓,
7400- Amla,    Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer
- Review, Var, NA
radioP↑, ChemoSen↑, chemoPv↑, *ROS↓, antiOx↑, Inflam↓, Imm↑, *hepatoP↑, *cardioP↑, *lipid-P↓, TumCCA↑, Chk2↑, CDK1↓, CycB/CCNB1↓, CDC25↓, TumMeta↓,
7907- Api,  IVT,    Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells
- Review, Var, NA
ChemoSen↑, CSCs↓, Wnt↓, β-catenin/ZEB1↓, PI3K↓, MMP↓, TumMeta↓, MAPK↓, VEGF↓, MMP9↓, TGF-β↓, Inflam↓, COX2/PTGS2↓, IL6↓, NF-kB↓, TumCCA↑, P53↑, cycD1/CCND1↓, BAX↑, Casp↓, Bcl-2↓, CD133↓, Nanog↓, SOX2↓, Akt↓, TumCP↓, TumCMig↓, YAP/TEAD↓, CCN2/CTGF↓, CCN1/CYR61↓, SIRT3↓, SIRT6↓, PCNA↓, DNMT1↓, miR-34a↑,
1149- Api,    Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
- vitro+vivo, IBD, NA
COX2/PTGS2↓, MPO↓, NF-kB↓, STAT3↓, Inflam↓,
1543- Api,    Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms
- Review, NA, NA
TNF-α↓, IL1β↓, IL6↓, IL10↓, COX2/PTGS2↓, iNOS↓, Inflam↓, Dose∅, Dose∅,
5405- ASA,    Exploring Aspirin’s Potential in Cancer Prevention: A Comprehensive Review of the Current Evidence
- Review, Var, NA
Risk↓, COX1↓, PGE2↓, Inflam↓, *AntiAg↓, PI3K↓, Akt↓, Risk↓,
3174- Ash,    Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
- in-vitro, HCC, HepG2 - in-vitro, HCC, Hep3B - in-vitro, HCC, HUH7
NF-kB↓, angioG↓, Inflam↓, TumCP↓, TumCMig↓, TumCI↓, Sp1/3/4↓, VEGF↓, angioG↓, uPA↓, PDGF↓, MCP1/CCL2↓, ICAM-1↓, *NRF2↑, *hepatoP↑,
3155- Ash,    Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera
- Review, Var, NA
Half-Life↝, Inflam↓, antiOx↓, angioG↓, ROS↑, BAX↑, Bak↑, E6↓, E7↓, P53↑, Casp3↑, cl‑PARP↑, STAT3↓, eff↑, HSP90↓, TGF-β↓, TNF-α↓, EMT↑, mTOR↓, NOTCH1↓, p‑Akt↓, NF-kB↓, Dose↝,
2002- Ash,    Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology
- Review, Var, NA
antiOx↑, Inflam↓, TumCP↓, OS↑, RadioS↑, radioP↑, chemoP↑,
5170- Ash,    Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ
- Review, Var, NA
NF-kB↓, Inflam↓, IKKα↓,
5174- Ash,    Withaferin A is a potent inhibitor of angiogenesis
- in-vitro, Nor, HUVECs
Inflam↓, *TumCP↓, cycD1/CCND1↓, NF-kB↓, angioG↓,
5175- Ash,    Withaferin A Induces Proteasome Inhibition, Endoplasmic Reticulum Stress, the Heat Shock Response and Acquisition of Thermotolerance
- in-vitro, Cerv, CCL-102
Inflam↓, AntiTum↑, Proteasome↓, ER Stress↑, HSPs↑, GRP94↑, Akt↑, eff↑, HSP70/HSPA5↑,
4824- ASTX,  Rad,    Astaxanthin protects the radiation-induced lung injury in C57BL/6 female mice
- in-vivo, Nor, NA
*radioP↑, Inflam↓,
4818- ASTX,  MEL,    Effect of astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, T47D - in-vitro, Nor, MCF10
TumCD↑, DNAdam↑, *antiOx↑, *AntiTum↑, Inflam↓, tumCV↓, Bcl-2↓, Apoptosis↓, selectivity↑, eff↑, Dose↓,
5249- Ba,  BA,    Baicalein and baicalin in cancer therapy: Multifaceted mechanisms, preclinical evidence, and translational challenges
- Review, Var, NA
Apoptosis↑, Inflam↓, TumCCA↑, ChemoSen↑, RadioS↑, TumCG↓, toxicity↓, BioAv↓, Half-Life↓,
5250- Ba,    Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment
- Review, Var, NA
Apoptosis↑, TumAuto↑, DNAdam↑, *antiOx↑, Inflam↓, PGE2↓, TumCCA↑, TumCMig↓, TumCI↓, angioG↓, selectivity↑, ChemoSen↑, HIF-1↓, cMyc↓, NF-kB↓, VEGF↓, P53↑, MMP2↓, CSCs↓, Bcl-xL↓, XIAP↓, survivin↓, tumCV↓, Casp3↑, Casp8↑, Bax:Bcl2↑, Akt↓, mTOR↓, PCNA↓, MMP↓, ROS↑, PARP↑, Casp9↑, BioAv↑, eff↑, P-gp/ABCB1↓, BioAv↑, selectivity↑,
2605- Ba,  BA,    Potential therapeutic effects of baicalin and baicalein
- Review, Var, NA - Review, Stroke, NA - Review, IBD, NA - Review, Arthritis, NA - Review, AD, NA - Review, Park, NA
cardioP↑, Inflam↓, cognitive↑, *hepatoP↑, *ROS?, *SOD↑, *GSH↑, *MMP↑, *GutMicro↑, ChemoSen↑, *TNF-α↓, *IL10↑, *IL6↓, *eff↑, *ROS↓, *COX2/PTGS2↓, *NF-kB↓, *STAT3↓, *PGE2↓, *MPO↓, *IL1β↓, *MMP2↓, *MMP9↓, *β-Amyloid↓, *neuroP↑, *Dose↝, *BioAv↝, *BioAv↝, *BBB↑, *BDNF↑,
2692- BBR,    Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis
- in-vitro, OS, MG63 - in-vitro, OS, SaOS2 - in-vivo, NA, NA
Casp1↓, IL1β↓, TumCG↓, Dose↝, Apoptosis↑, Inflam↓,
2674- BBR,    Berberine: A novel therapeutic strategy for cancer
- Review, Var, NA - Review, IBD, NA
Inflam↓, AntiCan↑, Apoptosis↑, TumAuto↑, TumCCA↑, TumMeta↓, TumCI↓, eff↑, eff↑, CD4+↓, TNF-α↓, IL1↓, BioAv↓, BioAv↓, other↓, AMPK↑, MAPK↓, NF-kB↓, IL6↓, MCP1/CCL2↓, PGE2↓, COX2/PTGS2↓, *ROS↓, *antiOx↑, *GPx↑, *Catalase↑, AntiTum↑, TumCP↓, angioG↓, Fas↑, FasL↑, ROS↑, ATM↑, P53↑, RB1↑, Casp9↑, Casp8↑, Casp3↓, BAX↑, Bcl-2↓, Bcl-xL↓, IAP1↓, XIAP↓, survivin↓, MMP2↓, MMP9↓, CycB/CCNB1↓, CDC25↓, CDC25↓, Cyt‑c↑, MMP↓, RenoP↑, mTOR↓, MDM2↓, LC3II↑, ERK↓, COX2/PTGS2↓, MMP3↓, TGF-β↓, EMT↑, ROCK1↓, FAK↓, RAS↓, Rho↓, NF-kB↓, uPA↓, MMP1↓, MMP13↓, ChemoSen↑,
2686- BBR,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, Nor, NA
Inflam↓, IL6↓, MCP1/CCL2↓, COX2/PTGS2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27/CDKN1B↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2/KDR/Flk1↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
5176- BBR,    Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice
- vitro+vivo, CRC, HCT116 - in-vitro, CRC, SW480 - in-vitro, CRC, LoVo
TumVol↓, Ki-67↓, COX2/PTGS2↓, AMPK↑, mTOR↓, NF-kB↓, cycD1/CCND1↓, survivin↓, P53↑, cl‑Casp3↑, TumCP↓, Inflam↓, COX2/PTGS2↓, ACC↑,
6512- BCP,    Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
- in-vitro, MM, NA
CB2 / CNR2↑, BAX↑, Bcl-2↓, Casp3↑, TumCP↓, Apoptosis↑, Akt↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, Inflam↓, chemoPv↑, neuroP↑, *BioAv↝, CB2 / CNR2↑, tumCV↓,
6499- BCP,    JAK1/STAT3 regulatory effect of β-caryophyllene on MG-63 osteosarcoma cells via ROS-induced apoptotic mitochondrial pathway by DNA fragmentation
- in-vitro, OS, MG63
ROS↑, Apoptosis↑, TumCP↓, BAX↑, Casp3↑, Bcl-2↓, MMP↓, DNAdam↑, TNF-α↓, COX2/PTGS2↓, NF-kB↓, IL6↓, Inflam↓, JAK1↑, STAT3↑,
6503- BCP,    The Potential Therapeutic Role of Beta-Caryophyllene as a Chemosensitizer and an Inhibitor of Angiogenesis in Cancer
- Review, Var, NA
ChemoSen↑, angioG↓, TumCI↓, TumMeta↓, ROS↑, *ROS↓, chemoP↑, CB2 / CNR2↑, Inflam↓, AntiTum↑, *BioAv↑, *BBB↑, Apoptosis↑, TumCP↑, TumCCA↑, RadioS↑, DNArepair↓, ROS↑, STAT3↓, *BioEnh↑, Pain↓, AntiBio↓, ROS↑, Dose↝, NF-kB↓, MAPK↓, TNF-α↓, IL1β↓, IL6↓, cl‑PARP↑, Casp↑, BAX↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, MMP2↓, p‑p38↓, p‑ERK↓, EPR↑, P-gp/ABCB1↓, MRP1/ABCC1↓, *NRF2↑, *antiOx↑,
2749- BetA,    Anti-Inflammatory Activities of Betulinic Acid: A Review
- Review, Nor, NA
Inflam↓, *NO↓, *IL10↑, *ICAM-1↓, *VCAM-1↓, *E-sel↓, *NF-kB↓, *IKKα↓, *COX2/PTGS2↓, *PGE2↓, *IL1β↓, *IL6↓, *IL8↓, *IL12↓, *TNF-α↑, *HO-1↑, *IL10↑, *IL2↓, *IL17↓, *IFN-γ↓, *SOD↑, *GPx↑, *GSR↑, *MDA↓, *MAPK↓,
5677- BML,    Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis
- in-vitro, Melanoma, A431 - in-vitro, Melanoma, A375
TumCP↓, Inflam↓, Akt↓, NF-kB↓, COX2/PTGS2↓, GSH↓, ROS↑, MMP↓, TumCCA↑, Apoptosis↑, ChemoSen↑,
5681- BML,    Supplementation Containing Bromelain on the Side Effects of Oncological Treatment: Systematic Review
- Review, Var, NA
Inflam↓, chemoP↑,
2777- Bos,    Inflammatory_Damage">Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage
- in-vitro, IBD, NA
*p‑NF-kB↓, *ROS↓, Inflam↓,
2775- Bos,    The journey of boswellic acids from synthesis to pharmacological activities
- Review, Var, NA - Review, AD, NA - Review, PSA, NA
ROS↑, ER Stress↑, TumCG↓, Apoptosis↑, Inflam↓, ChemoSen↑, Casp↑, ERK↓, cl‑PARP↑, AR↓, cycD1/CCND1↓, VEGFR2/KDR/Flk1↓, CXCR4↓, radioP↑, NF-kB↓, VEGF↓, P21↑, Wnt↓, β-catenin/ZEB1↓, Cyt‑c↑, MMP2↓, MMP1↓, MMP9↓, PI3K↓, MAPK↓, JNK↑, *5LO↓, *NRF2↑, *HO-1↑, *MDA↓, *SOD↑, *hepatoP↑, *ALAT↓, *AST↓, *LDH↑, *CRP↓, *COX2/PTGS2↓, *GSH↑, *ROS↓, *Imm↑, *Dose↝, *eff↑, *neuroP↑, *cognitive↑, *IL6↓, *TNF-α↓,
2773- Bos,    Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer
- Review, Var, NA
Inflam↓, TumCCA↑, Casp3↑, Casp8↑, Casp9↑, STAT3↑, SHP1↓, NF-kB↓, cycD1/CCND1↓, COX2/PTGS2↓, Ki-67↓, CD31/PECAM-1↓, IAP1↓, MMPs↓, Bcl-2↓, Bcl-xL↓,
6549- BSB,    (-)-α-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice
- in-vivo, Nor, NA
*antiOx↑, Inflam↓, *Dose↝, *neuroP↑, *motorD↑, *memory↑, *MPO↓, *TNF-α↓, *iNOS↓,
7947- BuckWS,    Anti-inflammatory effect of buckwheat sprouts in lipopolysaccharide-activated human colon cancer cells and mice
- vitro+vivo, Colon, NA
Inflam↓, *hepatoP↑,
5744- Buty,  PacT,    Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction
- in-vivo, Var, NA
chemoP↑, neuroP↑, Inflam↓, GutMicro↑, *ROS↓, Dose↝,
5742- Buty,    Butyrate: A Double-Edged Sword for Health?
- Review, Var, NA
HCAR2↑, Inflam↓, HDAC↓, *IFN-γ↓, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL10↑, *LTA/TNF-β↑, *NF-kB↓, *ROS↓, PPARγ↓, Weight↓,
5733- Buty,  VitB3,    Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
- in-vivo, CRC, NA
GutMicro↑, HCAR2↑, AntiCan↑, Inflam↓, IL18↑,
1650- CA,    Adjuvant Properties of Caffeic Acid in Cancer Treatment
- Review, Var, NA
ROS↑, antiOx↑, Inflam↓, AntiCan↑, NF-kB↓, STAT3↓, ERK↓, ChemoSen↑, RadioS↑, AMPK↑, eff↑, selectivity↑, COX2/PTGS2↓, Dose∅, PHDs↓, MMP9↓, MMP2↓, Dose∅, Dose∅, Ca+2↑, Dose?, MMP↓, RadioS↑,
5832- CAP,    Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells
- in-vitro, Oral, KB
TumCP↓, tumCV↓, TumCCA↑, Apoptosis↑, MMP↓, Casp9↑, Casp3↑, PARP↑, Inflam↓, Pain↓,
5202- CAP,    Capsaicin Suppresses Cell Proliferation, Induces Cell Cycle Arrest and ROS Production in Bladder Cancer Cells through FOXO3a-Mediated Pathways
- vitro+vivo, Bladder, 5637 - in-vitro, Bladder, T24/HTB-9
antiOx↑, Inflam↓, AntiCan↓, TRPV1↑, TumCP↓, TumCCA↑, ROS↑, FOXO3↑, TumCMig↓,
5894- CAR,    Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential
- Review, Var, NA
AntiCan↑, Apoptosis↑, Inflam↓, angioG↓, TumMeta↓, selectivity↑, BioAv↑, ChemoSen↑, Dose↝, TumCP↓, hepatoP↑, Casp3↑, Casp9↑, Bcl-2↓, ROS↑, GSH↓, BAX↑, Casp7↑, Casp8↑, Cyt‑c↑, Fas↑, FADD↑, P53↑, Bcl-2↓, TumMeta↓, TumCMig↓, TumCI↓, E-cadherin↑, TIMP2↑, TIMP3↑, N-cadherin↓, ZEB2↓, *lipid-P↓, *AST↓, *ALAT↓, *ALP↓, *LDH↓, *SOD↑, *Catalase↑, *GPx↑, *GSR↑, selectivity↑, cl‑PARP↑, ERK↓, p38↑, OS↑, AFP↓, COX2/PTGS2↓, VEGF↓, PCNA↓, Ki-67↓, TNF-α↓, BioAv↓,
5954- CEL,    The molecular mechanisms of celecoxib in tumor development
- Review, Var, NA
TumCP↓, TumCMig↓, TumCI↓, COX2/PTGS2↓, p‑NF-kB↓, Akt↓, MMP2↓, MMP9↓, Apoptosis↑, mitResp↑, ER Stress↑, TumAuto↑, ChemoSen↑, Inflam↓, PGE2↓, chemoPv↑, toxicity↓, Risk↓, PI3K↓, RadioS↑, TumCMig↓, TumCI↓, cJun↓, Sp1/3/4↓, ROS↑, MMP↓, MPT↑, Ca+2↑, Glycolysis↓, ATP↓, CSCs↓, Wnt/(β-catenin)↓, EMT↓, toxicity↝,
5938- Cela,    Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
- Review, Var, NA
AntiCan↑, BioAv↓, Apoptosis↑, TumAuto↑, TumCCA↑, TumMeta↓, angioG↓, Inflam↓, antiOx↑, ChemoSen↑, HSP90↓, ROS↑, RadioS↑, P53↑, NLRP3↓,
5941- Cela,    Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells
- in-vitro, Ovarian, SKOV3 - in-vitro, Ovarian, OVCAR-3
TumCMig↓, TumCI↓, NF-kB↓, p65↓, MMP9↓, eff↑, AntiTum↑, Inflam↓, AntiDiabetic↑,
5948- Cela,    Recent Trends in anti-tumor mechanisms and molecular targets of celastrol
TumCP↓, TumCCA↑, Apoptosis↑, TumAuto↑, TumCI↓, TumMeta↓, Imm↝, angioG↓, Cyt‑c↑, ROS↑, BAX↑, Casp3↑, Casp9↑, cl‑PARP↑, PrxII↓, ER Stress↑, mtDam↑, CHOP/DDIT3↑, Inflam↓, NF-kB↓, CXCR4↓, MMP9↓, IL6↓, TNF-α↓, HSP90↓, neuroP↑, STAT3↓, Prx↓, HO-1↑, eff↑, eff↑, BioAv↑, toxicity↑, CardioT↑, hepatoP↓,
2393- Cela,    Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
- in-vivo, Sepsis, NA - in-vitro, Nor, RAW264.7
OS↑, PKM2↓, Glycolysis↓, Warburg↓, Inflam↓, HMGB1↓, ALAT↓, AST↓, TNF-α↓, IL1β↓, IL6↓,

Showing Research Papers: 1 to 50 of 192
Page 1 of 4 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 192

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

AntiBio↓, 1,   CBR1↓, 1,   CCN1/CYR61↓, 1,   CUL1↝, 1,   CUL5↝, 1,   CX43/GJA1↓, 1,   DCR↑, 1,   DDIT4↑, 1,   HLA-I/II↑, 1,   IGF-2R↑, 1,   miR-106b↓, 1,   NA↑, 1,   NAT↓, 1,   NHEJ↓, 1,   NLR↓, 1,   NOD1↓, 1,   PGI2↓, 1,   PRKCQ/PKCθ↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 6,   antiOx↑, 28,   ARE↓, 1,   Catalase↓, 1,   Catalase↑, 3,   CYP1A1↓, 1,   CYP1A1↑, 1,   Ferroptosis↑, 2,   frataxin↑, 1,   GPx↑, 2,   GSH↓, 10,   GSH↑, 5,   GSTs↑, 1,   GSTs↝, 1,   HO-1↓, 2,   HO-1↑, 7,   HO-2↓, 1,   Iron↝, 1,   lipid-P↓, 2,   MDA↓, 1,   MDA↑, 1,   MPO↓, 3,   NRF2↓, 4,   NRF2↑, 7,   OXPHOS↓, 1,   OXPHOS↝, 1,   Prx↓, 2,   Prx4↑, 1,   PrxII↓, 1,   PYCR1↓, 1,   ROS↓, 9,   ROS↑, 70,   ROS⇅, 3,   mt-ROS↑, 1,   SIRT3↓, 1,   SIRT3↑, 1,   SOD↓, 3,   SOD↑, 4,   Trx↓, 1,   TrxR↓, 2,   TrxR1↓, 1,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 3,   IronCh∅, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

AIF↑, 2,   ATP↓, 7,   ATP↑, 1,   CDC25↓, 3,   EGF↓, 1,   FGFR1↓, 1,   MEK↓, 2,   mitResp↑, 1,   MMP↓, 29,   MPT↑, 2,   mtDam↑, 7,   OCR↓, 1,   Raf↓, 2,   XIAP↓, 9,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↑, 1,   ACLY↓, 1,   ALAT↓, 3,   AMPK↑, 7,   CAIX/CA9↓, 1,   cMyc↓, 10,   CRM↑, 1,   ECAR↓, 1,   ECAR↝, 1,   FAO↑, 1,   FASN↓, 1,   GlucoseCon↓, 3,   glut↓, 1,   Glycolysis↓, 11,   HK2↓, 5,   lactateProd↓, 5,   LDH↓, 6,   LDHA↓, 1,   lipidLev↓, 1,   lipoGen↓, 1,   NAD↑, 1,   NADPH↓, 2,   NADPH↑, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 1,   PFK↓, 1,   PKM2↓, 7,   PPARγ↓, 1,   PPARγ↑, 2,   p‑S6K↓, 1,   SIRT1↓, 1,   SIRT1↑, 2,   Warburg↓, 5,  

Cell Death(tgid=5) ⓘ

Akt↓, 32,   Akt↑, 2,   p‑Akt↓, 9,   APAF1↑, 3,   Apoptosis?, 1,   Apoptosis↓, 6,   Apoptosis↑, 63,   mt-Apoptosis↑, 1,   BAD↑, 2,   Bak↑, 4,   BAX↓, 1,   BAX↑, 25,   Bax:Bcl2↑, 7,   Bcl-2↓, 34,   Bcl-xL↓, 12,   BIM↓, 1,   Casp↓, 1,   Casp↑, 8,   Casp1↓, 1,   cl‑Casp1↓, 1,   Casp10↑, 1,   Casp3↓, 3,   Casp3↑, 36,   cl‑Casp3↑, 6,   Casp7↑, 5,   Casp8↑, 12,   Casp9↑, 28,   cl‑Casp9↑, 1,   CBP↓, 2,   Chk2↑, 1,   CK2↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 19,   Diablo↑, 1,   DR4↑, 2,   DR5↑, 5,   FADD↑, 1,   Fas↓, 1,   Fas↑, 5,   FasL↓, 1,   FasL↑, 1,   Ferroptosis↑, 2,   hTERT/TERT↓, 4,   IAP1↓, 4,   IAP2/BIRC3↓, 1,   IAP2/BIRC3↑, 1,   iNOS↓, 11,   iNOS↑, 1,   JNK↓, 2,   JNK↑, 8,   p‑JNK↓, 1,   p‑JNK↑, 3,   MAPK↓, 14,   MAPK↑, 5,   Mcl-1↓, 8,   MDM2↓, 4,   MDM2↑, 1,   MOMP↑, 2,   Myc↓, 1,   necrosis↑, 1,   NOXA↑, 2,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 7,   p38↑, 5,   p‑p38↓, 3,   p‑p38↑, 2,   Proteasome↓, 1,   PUMA↑, 3,   Pyro↑, 2,   survivin↓, 15,   Telomerase↓, 3,   TNFR 1↑, 1,   TRAIL↑, 2,   TRAILR↑, 1,   TRPV1↑, 1,   TumCD↑, 6,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

cSrc↓, 1,   HCAR2↑, 2,   HER2/EBBR2↓, 2,   Sp1/3/4↓, 5,  

Transcription & Epigenetics(tgid=7) ⓘ

cJun↓, 1,   p‑cJun↓, 1,   EZH2↓, 1,   H4↑, 1,   HATs↓, 3,   HATs↑, 1,   Matr↓, 1,   miR-218↑, 1,   other↓, 3,   other↑, 4,   other↝, 4,   PCAF↓, 2,   pRB↓, 2,   p‑pRB↓, 2,   tumCV↓, 20,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 5,   ER Stress↑, 8,   GRP94↑, 1,   HSP27↓, 1,   HSP70/HSPA5↑, 2,   HSP90↓, 3,   HSPs↑, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↑, 5,   p62↓, 2,   p62↑, 1,   SESN2↑, 1,   TumAuto↑, 19,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   BRCA1↑, 1,   DFF45↑, 1,   DNAdam↓, 3,   DNAdam↑, 14,   DNArepair↓, 1,   DNMT1↓, 2,   DNMT3A↓, 1,   MGMT↓, 1,   P53↑, 28,   p53 Wildtype↑, 1,   PARP↓, 1,   PARP↑, 3,   cl‑PARP↓, 1,   cl‑PARP↑, 15,   PCNA↓, 8,   SIRT6↓, 1,   SIRT6↑, 1,   TP53↓, 1,   γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   CDK1↑, 1,   CDK2↓, 8,   CDK4↓, 10,   Cyc↓, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 6,   cycD1/CCND1↓, 26,   cycE/CCNE↓, 5,   E2Fs↓, 1,   mitA↑, 1,   P21↓, 4,   P21↑, 12,   RB1↑, 2,   p‑RB1↓, 3,   TumCCA↓, 1,   TumCCA↑, 53,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH1A1↓, 1,   CD133↓, 3,   CD34↓, 1,   CD44↓, 1,   CDK8↓, 1,   CSCs↓, 14,   Diff↓, 2,   Diff↑, 4,   EMT↓, 19,   EMT↑, 2,   ERK↓, 18,   ERK↑, 2,   p‑ERK↓, 8,   FOXM1↓, 1,   FOXO3↑, 1,   GSK‐3β↓, 5,   HDAC↓, 5,   HDAC1↓, 1,   HDAC2↓, 1,   HDAC4↓, 1,   HDAC8↓, 2,   IGF-1↓, 1,   Jun↓, 1,   miR-34a↑, 3,   mTOR↓, 17,   p‑mTOR↓, 1,   p‑mTORC1↓, 1,   n-MYC↓, 1,   Nanog↓, 1,   Nestin↓, 1,   NOTCH↓, 4,   NOTCH1↓, 5,   NOTCH1↑, 1,   p300↓, 3,   PI3K↓, 28,   PI3K↑, 1,   PTEN↑, 11,   RAS↓, 5,   SHP1↓, 1,   SOX2↓, 2,   STAT↓, 4,   STAT1↓, 1,   STAT3↓, 28,   STAT3↑, 3,   p‑STAT3↓, 2,   STAT4↓, 1,   STAT6↓, 2,   TCF-4↓, 1,   TOP2↓, 1,   TumCG↓, 22,   Wnt↓, 12,   Wnt↑, 1,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 2,   AP-1↓, 3,   Ca+2↑, 5,   Ca+2↝, 2,   CC(CDKs/cyclins)↓, 1,   CCN2/CTGF↓, 2,   CD31/PECAM-1↓, 3,   COL1↓, 1,   COL3A1↓, 1,   E-cadherin↓, 1,   E-cadherin↑, 7,   FAK↓, 9,   p‑FAK↓, 1,   ITGB1↓, 2,   ITGB3↓, 1,   Ki-67↓, 11,   LEF1↓, 2,   MALAT1↓, 1,   miR-155↓, 1,   miR-19b↓, 1,   miR-200c↑, 1,   MMP1↓, 2,   MMP13↓, 2,   MMP2↓, 18,   MMP3↓, 2,   MMP7↓, 2,   MMP9↓, 26,   MMPs↓, 11,   MUC4↓, 2,   N-cadherin↓, 5,   PDGF↓, 1,   PKA↓, 1,   PKCδ↓, 4,   Rac1↓, 1,   RAGE↓, 1,   Rho↓, 1,   ROCK1↓, 1,   Slug↓, 4,   SMAD3↓, 1,   Snail↓, 7,   SOX4↑, 1,   TET1↑, 1,   TGF-β↓, 7,   TGF-β↑, 1,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP2↑, 1,   TIMP3↑, 1,   TRIB3↑, 1,   TSP-1↑, 1,   TumCA↓, 1,   TumCI↓, 34,   TumCMig↓, 25,   TumCMig↑, 1,   TumCP↓, 55,   TumCP↑, 1,   TumMeta↓, 30,   TumMeta↑, 1,   Twist↓, 4,   uPA↓, 5,   Vim↓, 5,   Zeb1↓, 4,   ZEB2↓, 1,   α-SMA↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 15,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 42,   ATF4↝, 1,   EGFR↓, 10,   p‑EGFR↓, 1,   Endoglin↑, 1,   eNOS↑, 1,   EPR↑, 1,   HIF-1↓, 3,   Hif1a↓, 11,   HIF2a↓, 1,   LOX1↓, 2,   NO↓, 5,   NO↑, 1,   PHDs↓, 1,   VEGF↓, 26,   VEGFR2/KDR/Flk1↓, 5,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 3,   CellMemb↑, 1,   GLUT1↓, 1,   IBI↑, 1,   NHE1↓, 1,   OATPs↓, 1,   P-gp/ABCB1↓, 4,   P-gp/ABCB1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 3,   CCR7↓, 1,   CD25+↓, 1,   CD4+↓, 2,   COX1↓, 2,   COX1↑, 1,   COX2/PTGS2↓, 49,   CRP↓, 5,   CXCR4↓, 7,   FoxP3+↓, 1,   HCAR2↑, 2,   HMGB1↓, 4,   ICAM-1↓, 3,   IFN-γ↓, 3,   IFN-γ↑, 1,   IKKα↓, 2,   IL1↓, 2,   IL10↓, 4,   IL10↑, 1,   IL17↓, 2,   IL17↑, 1,   IL18↓, 1,   IL18↑, 1,   IL1β↓, 21,   IL1β↑, 2,   IL2↑, 2,   IL22↓, 1,   IL23↓, 1,   IL4↓, 1,   IL6↓, 36,   IL6↑, 1,   IL8↓, 6,   IL8↑, 1,   Imm↑, 9,   Imm↝, 2,   INF-γ↓, 1,   Inflam↓, 192,   IκB↓, 1,   JAK↓, 3,   JAK1↓, 1,   JAK1↑, 1,   JAK2↓, 9,   MCP1/CCL2↓, 6,   MDSCs↓, 1,   MIP2↓, 1,   NF-kB↓, 70,   NF-kB↑, 2,   p‑NF-kB↓, 1,   p‑NF-kB↑, 1,   NK cell↑, 1,   p65↓, 2,   p‑p65↓, 2,   PD-L1↓, 2,   PGE2↓, 16,   PSA↓, 1,   TLR4↓, 5,   TNF-α↓, 33,   TNF-α↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

NOX↓, 1,   pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,  

Protein Aggregation(tgid=19) ⓘ

NLRP3↓, 5,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 4,   CDK6↓, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 20,   BioAv↑, 21,   BioAv↝, 2,   BioEnh↑, 2,   ChemoSen↓, 1,   ChemoSen↑, 51,   ChemoSen↝, 1,   Dose?, 3,   Dose↓, 2,   Dose↑, 2,   Dose⇅, 1,   Dose↝, 22,   Dose∅, 9,   DrugR↓, 1,   eff↓, 5,   eff↑, 58,   eff↝, 4,   eff∅, 2,   Half-Life↓, 4,   Half-Life↑, 1,   Half-Life↝, 5,   MDR1↓, 1,   MRP1/ABCC1↓, 2,   P450↓, 1,   P450↝, 1,   RadioS↑, 21,   selectivity↑, 31,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 3,   AR↓, 4,   AST↓, 3,   BRCA1↑, 1,   CRP↓, 5,   E6↓, 1,   E7↓, 1,   EGFR↓, 10,   p‑EGFR↓, 1,   EZH2↓, 1,   FOXM1↓, 1,   GutMicro↑, 6,   HER2/EBBR2↓, 2,   hTERT/TERT↓, 4,   IL6↓, 36,   IL6↑, 1,   Ki-67↓, 11,   LDH↓, 6,   Maspin↑, 1,   Myc↓, 1,   NOS2↓, 1,   PD-L1↓, 2,   PSA↓, 1,   RAGE↓, 1,   TP53↓, 1,   TRIB3↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 3,   AntiCan↑, 29,   AntiCan⇅, 1,   AntiDiabetic↑, 2,   antiNeop↑, 2,   AntiTum↓, 1,   AntiTum↑, 13,   AntiTum∅, 1,   cardioP↑, 7,   CardioT↑, 1,   chemoP↑, 19,   chemoPv↑, 10,   ChemoSideEff↓, 3,   cognitive↑, 2,   fatigue↓, 1,   hepatoP↓, 1,   hepatoP↑, 6,   hepatoP∅, 1,   memory↑, 3,   Mood↑, 1,   neuroP↑, 12,   NP/CIPN↓, 1,   OS↑, 9,   Pain↓, 3,   QoL↑, 3,   radioP↑, 9,   Remission↑, 1,   RenoP↑, 3,   Risk↓, 13,   Sleep↑, 1,   toxicity↓, 7,   toxicity↑, 3,   toxicity↝, 3,   toxicity∅, 1,   TumVol↓, 4,   TumW↓, 3,   Weight↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiViral↑, 1,   Bacteria↓, 1,  
Total Targets: 558

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

anemia↓, 1,   AntiBio↑, 1,   Aβ42↓, 1,   FPN↑, 1,   P-sel↓, 1,   RBC↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 18,   Catalase↑, 7,   Fenton↓, 1,   GPx↑, 6,   GSH↑, 8,   GSR↑, 2,   GSTs↑, 5,   H2O2↓, 1,   HO-1↑, 4,   Iron∅, 1,   lipid-P↓, 7,   MDA↓, 3,   MPO↓, 2,   NOX4↓, 1,   Nrf1↑, 1,   NRF2↑, 9,   RNS↓, 1,   ROS?, 1,   ROS↓, 30,   selenoP↑, 1,   SOD↓, 1,   SOD↑, 10,   TAC↑, 2,   TBARS↓, 1,   VitC↑, 1,   VitE↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

MMP↓, 1,   MMP↑, 1,   MMP∅, 1,   OCR↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   GAPDH↑, 1,   glucose↓, 1,   LDH↓, 1,   LDH↑, 1,   LDL↓, 1,   lipidLev↓, 1,  

Cell Death(tgid=5) ⓘ

Akt↑, 1,   Apoptosis↓, 1,   BAX↓, 1,   Bcl-2↑, 1,   Casp3↓, 2,   Cyt‑c↓, 1,   iNOS↓, 1,   p‑JNK↓, 1,   MAPK↓, 2,   p38↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP70/HSPA5↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 2,   P53↓, 1,   PARP↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

PTEN↓, 1,   STAT3↓, 1,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↓, 1,   Ca+2↓, 1,   E-sel↓, 1,   Fibronectin↓, 1,   ITGA5↓, 1,   ITGB1↓, 1,   MMP2↓, 1,   MMP9↓, 1,   TumCP↓, 1,   VCAM-1↓, 1,   α-SMA↓, 2,   α-tubulin↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 3,   CRP↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 2,   IKKα↓, 1,   IL1↓, 1,   IL10↑, 4,   IL12↓, 1,   IL17↓, 1,   IL1β↓, 5,   IL2↓, 1,   IL6↓, 9,   IL8↓, 4,   Imm↑, 2,   Inflam↓, 2,   LTA/TNF-β↑, 1,   NF-kB↓, 5,   p‑NF-kB↓, 1,   NK cell↑, 2,   PGE2↓, 2,   TNF-α↓, 6,   TNF-α↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↑, 3,   GABA↑, 1,   MAOA↓, 1,   tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 2,   β-Amyloid↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 9,   BioAv↑, 6,   BioAv↝, 6,   BioEnh↑, 1,   ChemoSen↑, 1,   Dose↑, 1,   Dose↝, 5,   eff↑, 5,   Half-Life↓, 1,   Half-Life↝, 1,   P450↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALP↓, 1,   AST↓, 2,   BG↓, 1,   BP↓, 1,   CRP↓, 1,   Ferritin↓, 1,   GutMicro↑, 3,   HemoG↑, 1,   IL6↓, 9,   LDH↓, 1,   LDH↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiArt↑, 1,   AntiCan↑, 1,   AntiDiabetic↑, 4,   AntiTum↑, 1,   cardioP↑, 8,   chemoPv↑, 2,   cognitive↑, 2,   hepatoP↑, 12,   memory↑, 3,   motorD↓, 1,   motorD↑, 1,   neuroP↑, 12,   Obesity↓, 1,   OS↑, 1,   QoL↑, 1,   radioP↑, 1,   RenoP↑, 1,   toxicity↓, 7,   toxicity↝, 1,   toxicity∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1,   Bacteria↓, 1,   Sepsis↓, 1,  
Total Targets: 154

Scientific Paper Hit Count for: Inflam, inflammation
9 Silymarin (Milk Thistle) silibinin
6 Ashwagandha(Withaferin A)
5 Fisetin
5 Chemotherapy
5 Thymoquinone
4 Radiotherapy/Radiation
4 Berberine
4 Celastrol
4 Crocetin
4 Diclofenac
4 Lycopene
4 Propolis -bee glue
4 Piperlongumine
3 Apigenin (mainly Parsley)
3 Baicalein
3 Beta-Caryophyllene
3 Boswellia (frankincense)
3 Butyrate
3 Chrysin
3 Curcumin
3 Fucoidan
3 Garcinol
3 Honokiol
3 IP6 (Inositol 1,2,3,4,5,6-hexakisphosphate)
3 Licorice
3 Quercetin
3 Resveratrol
3 Sulforaphane (mainly Broccoli)
3 Ursolic acid
2 Allicin (mainly Garlic)
2 Astaxanthin
2 Baicalin
2 Bromelain
2 Paclitaxel/Taxol
2 Capsaicin
2 Centella asiatica / Gotu kola → asiaticoside
2 Chocolate
2 Eugenol
2 Hydrogen Gas
2 Inositol
2 Kaempferol
2 Luteolin
2 Cisplatin
2 Nimbolide
2 Phenethyl isothiocyanate
2 Rosmarinic acid
2 Sulfasalazine
2 Selenite (Sodium)
2 Urolithin
1 1,8-Cineole
1 2-DeoxyGlucose
1 Astragalus
1 Silver-NanoParticles
1 Alpha-Lipoic-Acid
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Isovitexin
1 Aspirin
1 Melatonin
1 Betulinic acid
1 α-Bisabolol / Chamomile oil
1 buckwheat sprouts
1 Vitamin B3,Niacin
1 Caffeic acid
1 Carvacrol
1 Celecoxib
1 Chlorogenic acid
1 chaetocin
1 Cinnamon
1 Coenzyme Q10
1 Deguelin
1 Docosahexaenoic Acid
1 eicosapentaenoic acid
1 diet Short Term Fasting
1 Ellagic acid
1 Echinacea
1 Emodin
1 Electrical Pulses
1 Evodiamine
1 Ferulic acid
1 Gallic acid
1 Galloflavin
1 Ginkgo biloba
1 Germanium Organic/Ge-132 / propagermanium (organogermanium)
1 Geraniol
1 Gossypol/AT-101
1 Graviola
1 Grapeseed extract
1 HydroxyCitric Acid
1 Hydroxycinnamic-acid
1 HydroxyTyrosol
1 Hyperoside
1 iodine
1 Isoliquiritigenin
1 isoflavones
1 isoorientin
1 Lactobacillus
1 probiotics
1 Licochalcone A
1 Lecithin
1 Lactoferrin/Talactoferrin
1 SDG/lignans
1 Linalool
1 5-fluorouracil
1 Magnetic Fields
1 Naringin
1 Orlistat
1 Propyl gallate
1 Parthenolide
1 Salvia miltiorrhiza
1 Spermidine
1 Aflavin-3,3′-digallate
1 Turmerones
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:953  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page